Digging deeper into the specific mechanism revealed that RKO cells with truncated mutation TFAM showed reduced binding to HSPs, leading to decreased transcription of Cyt b and destabilization of mitochondria, which triggers significant proliferation of tumor cells and strong resistance to chemotherapy drugs. The gene discussed is TFAM; the disease is neoplasm.